First-pass extracted concept

chemogenetic methods

Candidate: concept label4 source documents9 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

chemogenetic

Extracted Explainers

What the tool is doing

The abstract identifies chemogenetic methods as one of the approaches associated with discovery of additional striatal GABAergic interneuron subtypes and their synaptic networks.

Source 2DOIPubMed

Chemogenetic methods are described as tools for functional circuit mapping in neuroscience and for studying seizure circuits in epilepsy.

Source 3DOIPubMed

What problem it solves

It helps extend functional analysis beyond earlier anatomical and electrophysiological descriptions.

Source 2DOIPubMed

They help probe circuit architecture and seizure-related pathways that may reveal therapeutic avenues.

Source 3DOIPubMed

What it does not solve

The abstract does not specify particular technical limitations or operational prerequisites.

Source 3DOIPubMed

Alternatives

Optogenetic methods are presented alongside chemogenetic methods as a contrasted and complementary approach.

Source 3DOIPubMed

Evidence Snippets

Chemogenetic methods, which combine the selective expression of designer receptors with designer drugs, have rapidly grown in use in the neurosciences, including in epilepsy.
Evidence 1Source 1DOIPubMedprovenance
With the application of new transgenic fluorescent reporter and Cre-driver/reporter lines, plus optogenetic, chemogenetic and viral transduction methods, several additional subtypes of novel striatal GABAergic interneurons have been discovered
Evidence 2Source 2DOIPubMedprovenance
Over the past decade, optogenetic and chemogenetic tools have enabled previously impossible levels of functional circuit mapping in neuroscience.
Evidence 3Source 3DOIPubMedprovenance
When these NTS neurons are activated using optogenetic or chemogenetic methods, food intake decreases and with chronic stimulation mice lose body weight.
Evidence 4Source 4DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1adoption or usagesupports2022Source 1DOIPubMed

Chemogenetic methods combining designer receptors with designer drugs have rapidly grown in use in neuroscience, including epilepsy.

Claim 2problem statementsupports2022Source 1DOIPubMed

Current epilepsy pharmacotherapies modulate neuronal excitability, but disrupting patterned neuronal excitation that is essential to normal function leads to side effects.

Claim 3problem statementsupports2022Source 1DOIPubMed

The efficacy of current pharmacotherapy for epilepsies remains incomplete despite decades of drug development.

Claim 4circuit architecturesupports2018Source 2DOIPubMed

Striatal GABAergic interneurons participate in highly selective afferent inputs and synaptic connections among interneuron subtypes and spiny neurons that form functional networks and ensembles of spiny neurons.

Claim 5method enabled discoverysupports2018Source 2DOIPubMed

New transgenic fluorescent reporter and Cre-driver/reporter lines together with optogenetic, chemogenetic, and viral transduction methods enabled discovery of additional subtypes of striatal GABAergic interneurons and the synaptic networks in which they are embedded.

Claim 6model revisionsupports2018Source 2DOIPubMed

The hypothesis that striatal GABAergic interneurons control spiny neuron firing principally by simple feedforward or feedback inhibition is incomplete.

Claim 7therapeutic rationalesupports2017Source 3DOIPubMed

Understanding network architecture at the level of local microcircuits and distributed macrocircuits may provide new therapeutic avenues for the treatment of epilepsy.

Quoted textsource-backed
Understanding the network architecture at the level of both local microcircuits and distributed macrocircuits may provide new therapeutic avenues for the treatment of epilepsy.
Claim 8utilitysupports2017Source 3DOIPubMed

Optogenetic and chemogenetic tools have enabled previously impossible levels of functional circuit mapping in neuroscience.

Quoted textsource-backed
Over the past decade, optogenetic and chemogenetic tools have enabled previously impossible levels of functional circuit mapping in neuroscience.
Claim 9functional effectsupports2016Source 4DOIPubMed

Activation of CCK-expressing and DBH-expressing NTS neurons using optogenetic or chemogenetic methods decreases food intake.

Quoted textsource-backed
When these NTS neurons are activated using optogenetic or chemogenetic methods, food intake decreases